Position in SPRY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,010
-$20 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#173
of 205 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Heritage Wealth Advisors holds $46,315 across 6 Biotechnology names. SPRY ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38 | $18,875 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28 | $17,459 | |
| 3 | SPRY |
ARS Pharmaceuticals, Inc.
This page
|
1,000 | $8,010 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6 | $1,806 | |
| 5 | GOSS |
Gossamer Bio, Inc.
|
1,000 | $165 | |
| 6 | VXRT |
Vaxart, Inc.
|
29,655 | $0 |
All Filings in SPRY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,010 | 1,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,030 | 1,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,650 | 1,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,050 | 1,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $17,450 | 1,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $12,580 | 1,000 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||